Susquehanna International Group, LLP Midatech Pharma PLC Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.46 - $1.0 $6,844 - $14,880	14,880 New	14,880 $8,000
Q4 2021 Feb 14, 2022	SELL	$1.05 - $1.85 $17,151 - $30,219	-16,335 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.68 - $2.19 $9,486 - $12,366	5,647 Added 52.83%	16,335 $28,000
Q2 2021 Aug 11, 2021	BUY	$1.78 - $2.95 $19,024 - $31,529	10,688 New	10,688 $22,000
Q1 2021 May 17, 2021	SELL	$1.92 - $3.8 $162,614 - $321,841	-84,695 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.77 - $2.36 $88,466 - $117,955	49,981 Added 143.98%	84,695 $159,000
Q3 2020 Nov 16, 2020	BUY	$1.29 - $4.3 $44,781 - $149,270	34,714 New	34,714 $63,000

Ticker MTP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 3,939,740
Market Cap $512K
Description
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.